Ibutamoren analog, also known as MK-677 or Nutrobal, is a non-peptide, orally active growth hormone secretagogue. This means it stimulates the body's own pituitary gland to release growth hormone (GH). It was originally developed to treat conditions such as growth hormone deficiency, osteoporosis, obesity, and muscle wasting. Unlike synthetic growth hormone, ibutamoren analog does not directly introduce exogenous GH into the body; instead, it acts on specific receptors to promote the natural pulsatile release of GH.
Deep dive
Tap a section to expand.
Known interactions
Category rule: peptide × hormone
Note
Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.
Track bloodwork with a provider; don't assume combinations are neutral.
Frequently asked
Sources referenced
["PubChem", "DrugBank", "NIH Office of Dietary Supplements (ODS)", "MedlinePlus", "Mayo Clinic", "Cochrane Library", "U.S. Food and Drug Administration (FDA)"]
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Ibutamoren Analog — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/ibutamoren-analog
Source attribution: DoseRoutine, https://doseroutine.com. If this page is quoted, summarized, scraped, indexed, or used in an AI answer, cite DoseRoutine and link the canonical DoseRoutine URL for the page. AI and crawler policy: https://doseroutine.com/llms.txt.